September 01, 2010Palau Pharma, member of the Board of Directors of the European Biopharmaceutical Enterprises... read more +
June 08, 2010Palau Pharma reports positive First-in-Man clinical trial results for its histamine H4 receptor antagonist UR-63325... read more +
March 08, 2010Palau Pharma unveils its new website today... read more +
February 16, 2010NEOGENIUS, the alliance between Almirall, Esteve, Palau Pharma and Proteomika, is to investigate new medicines for the treatment of osteoarthritis-induced pain... read more +
July 20, 2009Palau Pharma starts a Phase I clinical trial with a novel histamine H4 receptor antagonist... read more +
April 20, 2009Palau Pharma Initiates a Phase II Clinical Trial of Dersalazine Sodium in Mild to Moderate Ulcerative Colitis... read more +
May 07, 2008Palau Pharma's Partner, Iberhospitex, gains CE Approval for the Coronary Drug-Eluting Stent ACTIVE®... read more +
January 23, 2007Affectis Pharmaceuticals AG In-licenses Clinical Stage Compound for the Treatment of Psychiatric Disorders... read more +
November 01, 2006GRUPO URIACH launches Palau Pharma with the collaboration of several financial investors... read more +